LEXICON PHARMACEUTICALS, INC. (LXRX) › Cost of RevenueLEXICON PHARMACEUTICALS, INC. (LXRX) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $02017: $1.90M2018: $2.49M2019: $3.23M2020: $1.93M2021: $02022: $02023: $85.0K2024: $616.0K2025: $274.0K$274.0K2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$274.0K-55.5%2024$616.0K+624.7%2023$85.0K—2022$0—2021$0-100.0%2020$1.93M-40.3%2019$3.23M+29.7%2018$2.49M+31.2%2017$1.90M—2016$0—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share